Safety of Partial and Radical Nephrectomy for Complex Locally Advanced Renal Cell Carcinoma After Neo-Adjuvant Immune Checkpoint Inhibition: Analysis From a Phase 1b Trial (Durvalumab +/- Tremelimumab)

Posted by author-avatar

Publication date: October 2025

Source: Urology, Volume 204

Author(s): Jason M. Scovell, Brian I. Rini, Venkatesh Krishnamurthi, Jihad Kaouk, Christopher J. Weight, Moshe C. Ornstein, Georges Pascal-Haber, Mohamed Eltemamy, Shilpa Gupta, Steven C. Campbell, Joseph Zabell

Read More

Newer
State Medicaid Insurance Barriers to Vasectomy Coverage Are Associated With Restrictive Abortion Laws
Older Editorial Comment on “Safety of Partial and Radical Nephrectomy for Complex Locally Advanced Renal Cell Carcinoma After Neo-Adjuvant Immune Checkpoint Inhibition—Analysis From a Phase 1b Trial (Durvalumab +/- Tremelimumab)”